Author:
Di Renzo Gian Carlo,Meyyazhagan Arun,Tsibizova Valentina
Publisher
Springer International Publishing
Reference80 articles.
1. Carbone L, Cariati F, Sarno L, Conforti A, Bagnulo F, Strina I, Pastore L, Maruotti GM, Alviggi C. Non-invasive prenatal testing: current perspectives and future challenges. Genes (Basel). 2020;12(1):15.
2. Thomas GM, Rothman BK, Strange H, Latimer JE. Testing times: the social life of noninvasive prenatal testing. Sci Technol Soc. 2021;26(1):81–97.
3. Neufeld-Kaiser WA, Cheng EY, Liu YJ. Positive predictive value of noninvasive prenatal screening for foetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral centre. BMC Med. 2015;13:129.
4. Valderramos SG, Rao RR, Scibetta EW, Silverman NS, Han CS, Platt LD. Cell-free DNA screening in clinical practice: abnormal autosomal aneuploidy and microdeletion results. Am J Obstet Gynaecol. 2016;215(5):626.e1–626.e10.
5. BIS Research. Global noninvasive prenatal testing (NIPT) market: focus on tests, methods, platforms, applications, 26 countries’ analysis, patent landscape, and competitive landscape—analysis and forecast, 2018–2028. New York: Globe Newswire; 2019.